Discover Tenders by Ash Residues Containing Metals Sector

Find the most relevant tenders for Ash Residues Containing Metals. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Ash Residues Containing Metals tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Ash Residues Containing Metals tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Medicines Containing The Active Ingredient Rasagiline Atc N04Bd02

Deadline: 31 Jul 2026

Germany

Ref. No.: 7795935

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Medicines Containing The Active Ingredient Rasagiline Atc N04Bd02

Deadline: 31 Jul 2026

Germany

Ref. No.: 7795934

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Medicines Containing The Active Ingredient Febuxostat Atc M04Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 7795826

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Medicines Containing The Active Ingredient Febuxostat Atc M04Aa03

Deadline: 31 Jul 2026

Germany

Ref. No.: 7795825

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Medicines Containing The Active Ingredient Telmisartan Atc C09Ca07

Deadline: 31 Jul 2026

Germany

Ref. No.: 7790984

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Medicines Containing The Active Ingredient Telmisartan Atc C09Ca07

Deadline: 31 Jul 2026

Germany

Ref. No.: 7790983

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Combination Of Lopinavir And Ritonavir Atc Code J05Ar10

Deadline: 28 Jul 2026

Germany

Ref. No.: 7766088

EMD:Ref Document

Bid Value: Ref Document

316 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For Medicinal Products Containing The Active Ingredient Telmisartan Atc Code C09Ca07

Deadline: 28 Jul 2026

Germany

Ref. No.: 7747295

EMD:Ref Document

Bid Value: Ref Document

316 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Interferon Beta 1A L03Ab07 Subcutaneous Injection Within The Framework Of A So Call

Deadline: 31 Jul 2026

Germany

Ref. No.: 7708163

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Naproxen M01Ae02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7702625

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Rasagiline N04Bd02 Within The Framework Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7697176

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Miglustat A16Ax06 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7696670

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Lacosamide N03Ax18 Excluding Film Coated Tablets Within The Framework Of A So Call

Deadline: 31 Jul 2026

Germany

Ref. No.: 7693028

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Febuxostat M04Aa03 As Part Of A So Called Open House Model

Deadline: 31 Jul 2026

Germany

Ref. No.: 7690242

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Irbesartan And Hydrochlorothiazide C09Da24 Within The Framework Of A So Called Open

Deadline: 31 Jul 2026

Germany

Ref. No.: 7682368

EMD:Ref Document

Bid Value: Ref Document

319 Days Left

Showing 27856 to 27870 of 28074 results

‹
1
2
...
1855
1856
1857
1858
1859
1860
1861
...
1871
1872
›

Discover Tenders by Ash Residues Containing Metals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Ash Residues Containing Metals Sector

Filter Your Search

FREE Trial plan for all new users!